TargetMol

Mideplanin

Product Code:
 
TAR-T25812
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T25812-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25812-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Mideplanin is a glycopeptide antibiotic.
CAS:
122173-74-4
Molecular Weight:
1963.82
Purity:
0.98
SMILES:
O=C(NC1C(OC2C3=CC=C(OC4=CC5=CC(OC6=CC=C(C=C6Cl)CC7NC(=O)C(N)C8=CC=C(O)C(OC9=CC(O)=CC(=C9)C(NC7=O)C(=O)NC5C(=O)NC%10C(=O)NC2C(=O)NC(C(=O)NCCCN(C)C)C%11=CC(O)=CC(OC%12OC(CO)C(O)C(O)C%12O)=C%11C%13=CC%10=CC=C%13O)=C8)=C4OC%14OC(CO)C(O)C(O)C%14NC(=O)CCCCCCC(C)C)C(Cl)=C3)OC(CO)C(O)C1O)C

References

Goldstein BP, Candiani G, Arain TM, Roman? G, Ciciliato I, Berti M, Abbondi M, Scotti R, Mainini M, Ripamonti F, et al. Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic. Antimicrob Agents Chemother. 1995 Jul;39(7):1580-8. PubMed PMID: 7492108; PubMed Central PMCID: PMC162785. Trevi?o J, Bay?n C, Ard? A, Marinelli F, Gandolfi R, Molinari F, Jimenez-Barbero J, Hern?iz MJ. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy. Chemistry. 2014 Jun 10;20(24):7363-72. doi: 10.1002/chem.201303310. Epub 2014 May 7. PubMed PMID: 24805824. Gandolfi R, Jovetic S, Marinelli F, Molinari F. Biotransformations of lipoglycopeptides to obtain novel antibiotics. J Antibiot (Tokyo). 2007 Apr;60(4):265-71. PubMed PMID: 17456978. Venditti M, Tarasi A, Gelfusa V, Nicastri E, Penni A, Martino P. Antimicrobial susceptibilities of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother. 1993 May;37(5):1190-2. PubMed PMID: 8517714; PubMed Central PMCID: PMC187931.